136-150 of 825
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
NeuroFrontiersData Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
NeuroFrontiersIntermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
NeuroFrontiersEarly Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
NeuroFrontiersExploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
NeuroFrontiersQuantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
NeuroFrontiersCardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
- advertisement
Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
On the Frontlines of MigraineAssessing Sex-Based Treatment Responses to Gepants In Migraine Management
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
NeuroFrontiersTuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
John Golden
Michael Greenberg, MD
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
NeuroFrontiersTransforming Clinician Wellness: EEG Headphones Helping with Burnout
John Golden
Michael Greenberg, MD
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
On the Frontlines of CIDPPrioritizing Patient-Centered, Multidisciplinary Care in CIDP
Andrew G. Lee, MD
Ashley Baker, MSN, PMHNP
Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation
On the Frontlines of CIDPIdentifying CIDP: A Guide to Risk Profiles and Clinical Presentation
Nicolas Dubuisson, MD
Ryan Quigley
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
NeuroFrontiersGene Therapy Safety in DMD: How to Identify Common Immune Reactions
Kaitlin Batley, MD
- advertisement
Optimizing DMD Care Through Multidisciplinary Collaboration
NeuroFrontiersOptimizing DMD Care Through Multidisciplinary Collaboration
Kaitlin Batley, MD
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
NeuroFrontiersSymptom Control in gMG: Comparing Ravulizumab and Efgartigimod
Christopher A. Scheiner, MD, PhD
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
NeuroFrontiersExploring Timing in MS Therapy: Real-World Outcomes of Fumarates
